HopeStage
Back to all studies
CompletedNCT03684447

Propofol Dose and Brain Markers in Treatment-Resistant Depression

About this titleRead the official source — NCT03684447
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Salt Lake CitySee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 21, 2019
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
University of Utah
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT03684447
Official title
Show the full official title

Neural and Antidepressant Effects of Propofol

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Utah, a university.

Did this study involve medication?

Yes. The study involved medication, including Propofol.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies